These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dynamic antibody-binding properties in the pathogenesis of HIT. Sachais BS, Litvinov RI, Yarovoi SV, Rauova L, Hinds JL, Rux AH, Arepally GM, Poncz M, Cuker A, Weisel JW, Cines DB. Blood; 2012 Aug 02; 120(5):1137-42. PubMed ID: 22577175 [Abstract] [Full Text] [Related]
4. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia. Huynh A, Arnold DM, Kelton JG, Smith JW, Horsewood P, Clare R, Guarné A, Nazy I. J Thromb Haemost; 2019 Feb 02; 17(2):389-399. PubMed ID: 30582672 [Abstract] [Full Text] [Related]
6. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies. Kizlik-Masson C, Vayne C, McKenzie SE, Poupon A, Zhou Y, Champier G, Pouplard C, Gruel Y, Rollin J. J Thromb Haemost; 2017 Oct 02; 15(10):2065-2075. PubMed ID: 28771917 [Abstract] [Full Text] [Related]
14. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT. Krauel K, Preuße P, Warkentin TE, Trabhardt C, Brandt S, Jensch I, Mandelkow M, Hammer E, Hammerschmidt S, Greinacher A. Blood; 2019 Feb 28; 133(9):978-989. PubMed ID: 30573633 [Abstract] [Full Text] [Related]
19. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Huynh A, Kelton JG, Arnold DM, Daka M, Nazy I. Nature; 2021 Aug 28; 596(7873):565-569. PubMed ID: 34233346 [Abstract] [Full Text] [Related]